Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3860
-0.0009 (-0.23%)
At close: Mar 13, 2026, 4:00 PM EDT
0.3890
+0.0030 (0.78%)
After-hours: Mar 13, 2026, 7:49 PM EDT

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $500.00K in the twelve months ending September 30, 2025, down -50.00% year-over-year.

Revenue (ttm)
$500.00K
Revenue Growth
-50.00%
P/S Ratio
122.85
Revenue / Employee
$13,889
Employees
36
Market Cap
61.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Metagenomi Therapeutics25.21M
TScan Therapeutics10.33M
Alterity Therapeutics4.43M
Lipocine1.98M
BeyondSpring1.88M
ImageneBio800.00K
Entera Bio124.00K
InflaRx73.73K
Revenue Rankings

MREO News

More News